Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
Why Moderna Stock Is Surging Today
03:41pm, Thursday, 07'th Jul 2022 The Motley Fool
The biotech is benefiting from the broader market's gains.
3 Top Healthcare Stocks to Buy for July
10:00am, Thursday, 07'th Jul 2022 The Motley Fool
The future looks bright for these players.
Is Moderna Stock a No-Brainer Buy With Omicron Boosters on the Way?
09:52am, Thursday, 07'th Jul 2022 The Motley Fool
There's still significant risk associated with investing in this vaccine stock.
Coinbase, Moderna And 56 Biggest Movers From Yesterday
08:42am, Thursday, 07'th Jul 2022 Benzinga
Gainers
Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares climbed 75.2% to close at $2.19 after the company announced it has developed a non-invasive blood sensor designated to alert real-ti
Why Novavax Stock Lagged the Market on Wednesday
08:25pm, Wednesday, 06'th Jul 2022 The Motley Fool
The company is granted an important expansion of a CMA, however...
Novavax (NVAX) COVID Jab Receives EU Nod for Adolescents
05:06pm, Wednesday, 06'th Jul 2022 Zacks Investment Research
Novavax (NVAX) obtains EU approval for its Nuvaxovid COVID-19 vaccine for adolescents aged 12 through 17.
This May Be Pfizer's Key to Long-Term Vaccine Dominance
10:00am, Wednesday, 06'th Jul 2022 The Motley Fool
Can Pfizer keep on winning?
COVID hospitalizations dip for first time since mid-April, but daily deaths reach 2 1/2-month high
04:39pm, Tuesday, 05'th Jul 2022 MarketWatch
While the daily average of new COVID-19 cases have settled back into a low-100K range that has lasted for about seven weeks, hospitalizations took their first dip since mid-April and deaths ticked up
Can Moderna (MRNA) Keep the Earnings Surprise Streak Alive?
04:10pm, Tuesday, 05'th Jul 2022 Zacks Investment Research
Moderna (MRNA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Moderna Stock Is Jumping Today
03:42pm, Tuesday, 05'th Jul 2022 The Motley Fool
Investors are optimistic about the prospects for Moderna's omicron booster.
The Zacks Analyst Blog Highlights Pfizer, BioNTec and Moderna
10:36am, Tuesday, 05'th Jul 2022 Zacks Investment Research
Pfizer, BioNTec and Moderna are part of Zacks Analyst top Blog.
FDA and drug makers deepen their commitment to clinical-trial diversity. Will it work?
04:34pm, Saturday, 02'nd Jul 2022 MarketWatch
After years of ‘lackluster’ efforts, regulators and companies are finally aligned in their goal to make clinical trials more representative of U.S. population.
The U.S. bets billions of dollars on better COVID-19 boosters as it prepares for a spike in COVID-19 cases next winter
07:14pm, Friday, 01'st Jul 2022 MarketWatch
The U.S. is gearing up for another wave of COVID-19 infections in the fall and winter following a flurry of activity this week.
FDA Recommends Adding New Omicron Subvariants to COVID Boosters
01:45pm, Friday, 01'st Jul 2022 Zacks Investment Research
In anticipation of a new surge of COVID-19 infections later this year, the FDA recommends that COVID-19 vaccine manufacturers develop bivalent booster vaccines that contain the BA.4/BA.5 Omicron subva
Why This Company Could See Long-Lasting Tailwinds Despite the Bear Market
11:47am, Friday, 01'st Jul 2022 The Motley Fool
An industry-leading company looks past COVID-19 to future growth.
